Found 5 matching trials
A Study of AbGn-168H in Patients With Steroid Refractory Acute Graft-vs-Host Disease After Donor Stem Cell Transplant
PHASE1This study is to establish the safety, determine if there is an improvement...
Location
Stanford University, School of Medicine
Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease
PHASE1A Phase I study to establish the pharmacokinetics, pharmacodynamics, safety...
Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UC
PHASE2To evaluate the efficacy and safety of Neihulizumab (ALTB-168) administered...
Location
Lynn Institute of the Ozarks
Neihulizumab for Standard-Risk Acute Graft Versus Host Disease (GVHD)
PHASE1This is a single-center Phase I study to determine the maximum tolerated do...
Location
Froedtert Hospital and the Medical College of Wisconsin
A Study Evaluating the Efficacy and Safety of Neihulizumab vs "Conventional Treatment" to Treat Sr-aGvHD
PHASE2This study is to assess the efficacy of Neihulizumab versus "conventional t...
Location
MD Anderson Cancer Center